SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001628280-22-007967
Filing Date
2022-03-31
Accepted
2022-03-31 11:42:01
Documents
10

Document Format Files

Seq Description Document Type Size
1 424B3 pointbiopharmaglobalinc-42.htm 424B3 1846430
2 business1a.jpg GRAPHIC 180015
3 business2a.jpg GRAPHIC 188581
4 business3a.jpg GRAPHIC 161853
5 business4a.jpg GRAPHIC 237063
6 business5a.jpg GRAPHIC 157155
7 business6a.jpg GRAPHIC 230098
8 business7a.jpg GRAPHIC 290136
9 pointlogo1a.jpg GRAPHIC 50640
10 pointlogo1a1.jpg GRAPHIC 91012
  Complete submission text file 0001628280-22-007967.txt   4026057
Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (647) 401-2182
POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-258325 | Film No.: 22790469
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences